Seer

Scale your proteomics with depth, speed, and confidence. The Proteograph Product Suite enables deep, high-throughput proteomic analysis—identifying up to 10x more protein groups than direct digest methods, with just one MS injection per sample. Process up to 1,000 samples per week with the SP200 Automation Instrument, all in <5-hour runs that fit easily into a standard shift. Compatible with diverse sample types across human and non-human species, Proteograph helps you uncover more of the proteome—so you can focus on what matters: discovery. Learn more: https://xmrrwallet.com/cmx.plnkd.in/eFMxTeKr #Proteomics #MassSpectrometry #Automation #LifeSciences #SeerBio #ProteinDiscovery

The Proteograph Product Suite, featuring the Proteograph ONE Assay, brings the proteome into full view — delivering deep, reproducible, unbiased analysis for studies at scale. Learn more: https://xmrrwallet.com/cmx.plnkd.in/eFMxTeKr Designed to: •Unlock large-scale studies with the Proteograph ONE Assay •Optimize reproducibility and throughput with the SP200 Automation Instrument •Accelerate deep biological insights with the Proteograph Analysis Suite With the Proteograph Product Suite, Seer enables you to uncover the insights that will elevate your advantage in proteomics—revealing more of the proteome for you, so you can unveil new discoveries for the world. #Proteomics #MassSpectrometry #Automation #LifeSciences #SeerBio #ProteinDiscovery

We had a fantastic time this week at the Cascadia Proteomics Symposium, hosted by the Institute for Systems Biology! It was inspiring to see the diversity of proteomics strategies presented—from emerging workflows to novel biological insights. We’re grateful to everyone who joined Seer’s talk, stopped by our booth, or simply engaged in the science.   Whether you're exploring biomarker discovery, model organisms, or translational proteomics, we’re here to help deepen your insight. Learn what Seer can do for you a https://xmrrwallet.com/cmx.pseer.bio/ #Proteomics #SystemsBiology #MassSpec #CascadiaProteomics #LifeScience #SeerBio #BiomarkerDiscovery #TranslationalResearch #ModelOrganisms Spencer Servizi  

Uncovering the depth of the plasma proteome - linking genotype to phenotype Professor Claudia Langenberg and Professor Maik Pietzner (Queen Mary University of London), recently conducted a large-scale proteomics study in a genetically enriched cohort of 1,500 individuals, integrating data from Seer, Olink, SomaLogic, and whole-genome sequencing. By unlocking previously untapped mass spectrometry (MS) data using Seer's deep unbiased approach, they revealed novel insights into plasma proteomics and proteogenomics. Webinar Link: https://xmrrwallet.com/cmx.plnkd.in/gkemF-Hs Key Findings: • 8,000+ proteins detected, underscoring the power of deep proteome coverage for large-scale population studies • Complete peptide absence in loss-of-function homozygotes - demonstrating how MS can resolve functional consequences beyond the reach of affinity-based methods • Deep MS reveals protein-altering variants as key drivers of plasma protein variation - highlighting functional effects that are difficult to detect with affinity-based approaches • 1,200+ pQTLs identified, over 50% novel, including 140 within already studied genes - a discovery scale previously requiring up to 40x more samples • 690 genetic associations colocalized with disease-relevant cellular signals   Overall, this work redefines what’s possible in population-scale proteomics - showing that deep MS can uncover biological insights previously out of reach. These findings pave the way for larger studies to fully realize its potential in precision medicine. #Proteomics #Genomics #MassSpec #pQTL #Proteogenomics #PlasmaProteome #PrecisionMedicine #Seer #PopulationHealth #Biobanking #Epidemiology #Cohorts #pGWAS #GWAS

The countdown is on! Join us tomorrow for a live webinar featuring leading experts Claudia Langenberg, PhD, and Maik Pietzner, PhD, presenting “Unlocking the Power of High-Throughput Proteomics: Insights From Cutting-Edge Proteogenomic Research” > Date: July 15 > Time: 10:00am PT, 1:00pm ET > Speakers: >> Claudia Langenberg, PhD - Director, Precision Healthcare University Research Institute, Queen Mary University of London >> Maik Pietzner, PhD - Chair, Health Data Modelling, Queen Mary University of London Register here today: https://xmrrwallet.com/cmx.plnkd.in/gETyUXEP #Seer #Proteomics #Biotech #Lifesciences

Seer’s 2025 Insights Grant Program is closing soon—don’t miss this opportunity to submit your application and propel your proteomics research forward. > Application deadline: July 18 > Grant recipients notified: August 4 > Apply now: https://xmrrwallet.com/cmx.plnkd.in/gyQax_gb Past recipients have leveraged this grant to make significant strides in discovery. As Dr. Jerry Zak, Staff Scientist at The Scripps Research Institute, shared: “By applying Seer’s Proteograph technology, we're identifying changes associated with the response to experimental immunotherapies. This unbiased approach reveals cellular and molecular changes which inspire mechanistic studies and potentially reveal which patients are most likely to benefit from these therapies.” Whether you’re pushing the boundaries of neurology or cardiometabolics, this grant can provide the platform—and the technology—to accelerate your work. #Proteomics #MassSpectrometry #LifeSciences #SeerBio

You’re invited to an insightful webinar featuring Claudia Langenberg, PhD, and Maik Pietzner, PhD, as they present: “Unlocking the Power of High-Throughput Proteomics: Insights From Cutting-Edge Proteogenomic Research” > Date: July 15, 2025 > Time: 10:00 AM PT | 1:00 PM ET | 7:00 PM CET > Register here: https://xmrrwallet.com/cmx.plnkd.in/gETyUXEP (edited)  We look forward to an engaging session with two of the field’s most respected voices. Don’t miss it! #Proteomics #MassSpectrometry #LifeSciences #SeerBio

New Preprint Alert in bioRxiv: Deep and Quantitative Proteomic Profiling of Low-Volume Mouse Serum Across the Lifespan A new study led by Dr. Nate Basisty and now available on bioRxiv showcases a powerful Proteograph application for deep, quantitative proteomics using just 20 µL of mouse serum—enabling transformative insights for aging and longitudinal research.   Key Highlights: 1. Deep Coverage from Tiny Volumes The study used Seer’s nanoparticle-based Proteograph™ workflow to identify ~4,000 proteins from 20 µL of serum—achieving a 2–4x increase in proteomic depth compared to conventional mass spectrometry approaches. 2. Reproducibility Across the Lifespan With CVs under 10%, the workflow demonstrated exceptional reproducibility across replicates and time points—critical for detecting subtle biological changes over time. 3. Unlocking Insights in Sample-Limited Studies The study enabled robust proteomic profiling in aging mice—even with limited serum volumes—making biomarker discovery possible in highly sample-constrained contexts.   This work redefines what’s possible in small-animal proteomics and opens new doors for discovery in aging biology. 🔗 https://xmrrwallet.com/cmx.plnkd.in/ge6Mje9J   #Proteomics #MassSpec #AgingResearch #MouseModels #Biomarkers #LifeSciences #SeerBio #Proteograph #BasistyLab #bioRxiv

Great insights from the 3rd Oxford Symposium on Human Proteome and Health! A highlight was the talk by Professor Maik Pietzner, from Queen Mary University of London, titled “Genetic determinants of a deep plasma proteome across the allele frequency spectrum.” His presentation, based on data from the Genes & Health population cohort, spotlighted the power of genomics when paired with deep proteomic profiling. We’re proud that Seer’s nanoparticle technology played a key role in enabling these discoveries—pushing the boundaries of population-scale proteomics. Want to learn more? Join our upcoming webinar on July 15 for a deeper dive into these groundbreaking insights. Register here: https://xmrrwallet.com/cmx.plnkd.in/gETyUXEP #Genomics #Proteomics #PopulationHealth #OxfordSymposium #SeerTechnology #BiotechInnovation #PlasmaProteome #MaikPietzner #QueenMaryUniversity #Seer

Seer at the Forefront of Proteomics Innovation – Live from Oxford A highly insightful panel took place at the 3rd Annual Symposium on Human Proteome and Health in Oxford, UK, spotlighting strategic approaches to large population cohorts. Among the industry leaders, Dr. Serafim Batzoglou, Seer's Chief Data Officer, shared how Seer’s nanoparticle-based technology is reshaping what’s possible in proteomics. He emphasized our fully automated, scalable platform—uniquely designed to deliver the broadest, deepest view of the human proteome at population scale. We’re proud to be part of this global conversation on the future of health. Say hello to the Seer team in Oxford: Serafim Batzoglou, Lars Vahlkamp, Maik Prüss, Catherine Gilbert, and Bijon Chatterji. We’d love to connect! #Proteomics #PopulationHealth #HumanProteome #Seer #Innovation #LifeSciences #OxfordSymposium #MassSpec #Biotech